WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin LeeCHIEF EXECUTIVE OFFICER2026-07-061,737$4.31
$7.49kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2026-07-06255$4.31
$1.10kSell
Michael SkynnerCHIEF SCIENTIFIC OFFICER2026-07-06532$4.31
$2.29kSell
Jennifer Scott PerryChief Operating Officer2026-07-0643$4.31
$185.33Sell
Travis Alvin ThompsonChief Financial Officer2026-07-06104$4.31
$448.24Sell
Jennifer Scott PerryChief Operating Officer2026-07-06333$4.34
$1.45kSell
Jennifer Scott PerryChief Operating Officer2026-07-021,036$4.27
$4.42kSell
Travis Alvin ThompsonChief Financial Officer2026-07-02819$4.27
$3.50kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2026-07-021,506$4.27
$6.43kSell
Michael SkynnerCHIEF SCIENTIFIC OFFICER2026-07-021,859$4.27
$7.94kSell

1 of 5

BCYC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP14.31%10,018,674$39.97MInsider
Carolyn Ng2.86%1,998,580$7.97MInsider
Tybourne Capital Management Hk Ltd2.80%1,957,961$7.81MInsider
Deborah Harland2.74%1,915,275$7.64MInsider
Svlsf V LLC2.74%1,915,274$7.64MInsider
Glaxosmithkline PLC2.73%1,910,531$7.62MInsider
Kate Bingham2.73%1,910,016$7.62MInsider
Novartis Bioventures Ltd2.53%1,769,641$7.06MInsider
Michael Anstey2.50%1,751,437$6.99MInsider
Cambridge Innovation Capital Jersey Ltd2.50%1,751,437$6.99MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC0.05%43.51%Net SellingNet Selling
RNAC0.02%99.98%Net Buying
YDES0.00%3.73%
SRZN0.06%99.94%Net BuyingNet Selling
TRDA0.07%99.93%Net SellingNet Selling
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 0.05% institutional shareholders, 43.51% Bicycle Therapeutics insiders, and 56.43% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 10.02M shares representing 14.31% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $39.97M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.